• Targeting Key Protein in CMT Type 2A May Be Basis of Future Therapies, Study Suggests
  • What I Am and What I Am Not
  • #AAN2018 – Autonomic Nerve Damage Is Widespread and Greatly Affects CMT Patients, Study Shows
  • #AAN2018 – Neuropathy-based Scale May Help Predict Mobility Needs in Children with CMT
  • Shoes Are Not Always My Friend
  • Clinical Trial to Test New Tool for Assessing CMT’s Severity in Children
  • Pharnext, Developer of CMT1A Treatment Candidate PXT3003, Raises 16 Million Euros
  • NIH Agency Pioneers Collaborative Research into Rare Diseases
  • Balance Walking for CMT May Help Patients Stay Fit, Be Healthier
  • Protein Component May Lead to More Severe Case of CMT4F, Mouse Study Suggests
  • Creating Balance to Ward Off Anxiety
  • Sox2, Id2 Proteins Play Protective Role in Preventing Cell Damage, CMT1B Mouse Study Finds